Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03815760
Other study ID # 2181055
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 18, 2019
Est. completion date May 30, 2019

Study information

Verified date January 2019
Source George Fox University
Contact Jason Brumitt, PhD
Phone 5035542461
Email jbrumitt@georgefox.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the ability of blood flow restriction therapy to improve strength of shoulder muscles during the sidelying external rotation (ER) exercise versus a control group who only performs the sidelying ER exercise.


Description:

The purpose of this study is to determine if blood flow restriction (BFR) therapy is superior at increasing strength of the shoulder (supraspinatus, infraspinatus, posterior deltoid, and middle deltoid) and increasing tendon size of the supraspinatus and infraspinatus (as determined by diagnostic ultrasound) while performing the sidelying external rotation exercise compared to those who only perform the sideyling external rotation exercise without BFR.

Subjects will be randomized to one of two treatment groups: exercise with BFR or exercise alone. Recruitment will be a sample of convenience consisting of healthy adults (age range 22 to 45). Subjects will perform the sidelying external rotation exercise 2 times a week for an 8 week period.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date May 30, 2019
Est. primary completion date May 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

1. Healthy adult (age 18 and older) with no current shoulder pathology

Exclusion Criteria:

1. Current neck, shoulder (or general upper extremity), and/or thoracic spine pathology

2. Shoulder surgery (or general upper extremity surgery) during the prior 6-month time period

3. Cervical/thoracic spine surgery during the prior 1 year

4. Subject having one or more contraindications for BFR training.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Blood Flow Restriction
Subjects will perform sidelying external rotation exercise

Locations

Country Name City State
United States George Fox University School of Physical Therapy Newberg Oregon

Sponsors (1)

Lead Sponsor Collaborator
George Fox University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscular Strength as Measured by Dynamometry Use a hand held dynamometer (MicroFet 2) to measure strength of the middle and posterior deltoid, the supraspinatus, and the infraspinatus Change from Baseline to 8-weeks
Primary Tendon Size as Measured by Diagnostic Ultrasound Ultrasound images are capture at pre- and post-test sessions Change from Baseline to 8-weeks
See also
  Status Clinical Trial Phase
Completed NCT03693521 - Effects of Measurement of Handgrip Strength on Physical Activity Level for Patients With Diabetes Type 2 N/A
Completed NCT04118725 - Muscular Respiratory Involvement and Systemic Sclerosis N/A
Active, not recruiting NCT01225614 - Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive Phase 3
Completed NCT03670563 - Training Intrinsic Foot Muscles N/A
Completed NCT04154098 - Evaluation of a Textile Scapula Orthosis N/A
Completed NCT03543488 - Neuromusuclar Adaptations in the Rheumatoid Arthritis Disease
Recruiting NCT03055182 - Oxygenation of Paravertebral Muscles During Exercise in Chronic Low Back Pain Patients N/A
Completed NCT02042937 - Enhancing Gluteus Maximus Recruitment N/A
Completed NCT03194997 - Pilates and Dance to Breast Cancer Patients Undergoing Treatment N/A
Completed NCT03457740 - Supplement Study: Strength, Testosterone, Sexual Function, Quality of Life N/A
Completed NCT04770987 - Lateral Neck Flexor Endurance and Hyperlaxity
Withdrawn NCT01457443 - Biomarker for Pompe Disease (BioPompe)
Completed NCT02994030 - Biomarker for Duchenne Muscular Dystrophy